The Idylla™ EGFR Mutation Test, performed on the Biocartis Idylla™ system, is a fully automated, real-time PCR,  in vitro diagnostic test for the qualitative detection of 51 mutations

in exons 18-21. EGFR mutation testing in exons 18-21 is recommended in all patients with advanced NSCLC of a non-squamous subtype.

The mutation test allows detection of EGFR mutations directly from formalin-fixed paraffin-embedded (FFPE) tissue sections in approximately 2 hours, and is suitable for the detection of the T790M resistance mutation.

To order, please complete Austin Molecular Solid Tumour Test Request Form indicating the test required and the biopsy number and date of collection of the sample you wish to be tested.

To be bulk billable please get the patient to sign the Medicare assignment, or if they are unable to do so, please sign on their behalf.